Regeneron Pharmaceuticals Inc (REGN)
Publicly reported company facts and saved market data for Regeneron Pharmaceuticals Inc (REGN), with sources and as-of times. Saved data is not a live quote.
Company profile
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous approved treatments and product candidates in development, most of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. Regeneron pushes the boundaries of scientific discovery and accelerates drug development using our proprietary technologies, such as VelociSuite , which produces optimized fully human antibodies and new classes of bispecific antibodies.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $96.0B · as of
- Incorporated in
- United States
- Company website
- www.regeneron.com
- Exchange
- NASDAQ
Saved quote
Saved snapshot, not a real-time quote. Check the market time before relying on it.
- Last reported price
- $926
- Reported change
- +13.10%
- Reported volume
- 2,851,707
- Latest market time
Float and shares outstanding
| Measure | Shares | As of | Source and basis |
|---|---|---|---|
| Float | 95,706,739 | Reported by a single source; not cross-checked. | |
| Shares outstanding (O/S) | 93,955,110 | SEC 10-Q filing · filed Historical: the latest SEC-reported figure is more than six months old. |
Dates are measurement dates, not the time FennEdge retrieved the data. Float references are listed separately; they are not averaged or adjusted for later splits or share issuances.
Short interest
- Reported short interest
- 2,134,934 shares
- Settlement date
- Source
- Market and company data
Exchange-published short interest for the stated settlement date, not a live short position.
Recent daily sessions
The 10 most recent saved daily sessions, through . Daily OHLC and volume; not real-time.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| 826.14 | 828.19 | 811.63 | 818.77 | 789,303 | |
| 807.06 | 821.16 | 802.20 | 813.27 | 536,498 | |
| 807.67 | 816.14 | 804.05 | 816.10 | 726,151 | |
| 812.31 | 817.17 | 796.61 | 807.67 | 423,958 | |
| 819.09 | 819.09 | 801.22 | 805.02 | 527,739 | |
| 809.01 | 825.52 | 800.00 | 819.09 | 852,594 | |
| 806.74 | 813.86 | 800.24 | 805.67 | 581,051 | |
| 793.85 | 807.86 | 789.69 | 807.48 | 623,400 | |
| 792.59 | 800.00 | 780.83 | 782.04 | 489,580 | |
| 803.01 | 805.67 | 787.32 | 790.74 | 653,725 |
Dilution timeline
As of
- · S-3ASR · Shelf registration filed
Parsed share counts, prices and warrant terms require Plus or above. Explore plans
Research this company
FennEdge organizes SEC filings and reported market data. Sign in for additional research and your private trading context.
Sign in to continue